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We are used to reading that Chlamydia trachomatis (CT) infection in pregnancy is associated with a 
range of adverse outcomes, including preterm birth, low birthweight, spontaneous abortion, 
intrauterine growth restriction and neonatal death.1 2 These statements, often in the introduction to 
commentaries or research studies, are accompanied by references to general textbooks,3 or studies 
in which strong associations have been found.4 5 But how sure are we of these findings, why do we 
want to know and what can we learn?  
Tang and colleagues have done a systematic review and meta-analysis,6 which substantially 
strengthens the completeness of the evidence-base about the association between CT and adverse 
reproductive outcomes. They reviewed reports of 107 observational epidemiological studies (case-
control, cohort or cross-sectional) published up to May 2018. Following good practice in systematic 
reviews of observational studies of aetiology,7 they defined the research question in a published 
protocol, stratified results by study design, provided unadjusted and confounder-adjusted estimates 
where available, assessed the risk of bias, and examined reasons for heterogeneity. The 107 studies 
in this review reported on any of 12 outcomes of pregnancy or fertility. Tang et al.’s extensive review 
is important for three main reasons. First, it is probably the largest systematic review of studies 
reporting on associations between C. trachomatis and reproductive outcomes. Second, the review 
finds empirical evidence that study setting, study design and analysis are associated with the 
strength of associations. Third, this review makes us think about what research studies are needed 
next.  
In observational studies of aetiology, there are multiple sources of bias that affect their 
interpretation. In an earlier systematic review, Olson-Chen et al. examined eight adverse outcomes 
of pregnancy, but not fertility, and included 56 studies published between 1970 and 2013,8 with 
some overlap in outcomes and included studies with Tang et al. In both reviews, the strength of 
association was smaller in studies judged to be of better methodological quality.6 8 In neither review, 
however, did the authors identify which specific biases were associated with attenuation in the 
effect size. With so many outcomes and results, it can be hard to examine and discuss them all in 
detail. This commentary is a chance to examine, in a bit more detail, two methodological issues for 
systematic reviews and individual studies that could either overestimate or underestimate the 
strength of association between CT and adverse outcomes and discuss implications for future 
research, focusing on STIs in pregnancy. 
Pregnancy is an interesting and special case for observational epidemiological studies. From 
beginning to end, it can be seen as a short cohort study. This short duration reduces some of the 
differences in the ‘conventional’ strengths and weaknesses between study designs.9 For example, in 
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the assessment of causality, cross-sectional studies are usually seen as providing low certainty 
evidence, followed by case-control studies, with prospective cohort studies being the strongest 
observational design.10 This hierarchy may be true for chronic conditions and ongoing exposures 
because the temporal sequence of cause and effect cannot be determined and may be affected by 
recall bias in cross-sectional and some case-control studies. In cohort studies, the exposure status is 
defined first and its association with new, incident cases of the outcome determined during follow-
up. If the study is examining outcomes of pregnancy, such as preterm delivery, the end of the 
pregnancy defines both the occurrence of the outcome and the end of a woman’s involvement in 
the cohort study. 
Confounding  
Confounding is the major threat to the internal validity of observational epidemiological studies, so 
in a systematic review, the confounder-adjusted summary effect will provide the most useful 
information for questions about aetiology.7 CT and pregnancy are both sexually acquired, so many 
factors, including younger age, smoking, lower socio-economic position and belonging to black or 
indigenous minority ethnic groups,11 are associated with both and could plausibly result in 
systematic overestimation of exposure-outcome association. Tang et al. chose to present unadjusted 
analyses as their primary outcome, because these were more often reported (178 effect estimates) 
than adjusted estimates (51 estimates). For outcomes with both univariable and multivariable 
analyses, the unadjusted estimate was higher than the adjusted estimate in 16 of 19 pairs, 
suggesting that confounding is present. For example, for preterm labour, the unadjusted and 
adjusted risk ratios in cohort studies were 1.54 (95% confidence interval, CI 1.48-1.60) and 1.09 (95% 
CI 1.03-1.15) and odds ratios in case-control studies were 1.29 (95% CI 1.11-1.50) and 1.15 (95% CI 
0.95-1.39) respectively.6   
The presence of other genital tract infections, which are commonly found in women with CT and are 
also associated with specific outcomes, could also result in confounding. Tang et al. did not report on 
co-infections and whether these had been measured or included in multivariable analyses. They did 
find that unadjusted effect estimates from case-control studies were higher in low- and middle-
income countries where, plausibly, women are both more likely to have had other genital tract 
infections associated with adverse pregnancy outcomes and might also have been less likely to have 
received treatment.  
Measurement bias 
The investigation of associations between curable infections and pregnancy outcomes brings special 
challenges because treatment, at an early enough stage, could reduce or eliminate the risk of the 
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outcome. Indeed, that is usually the intention of treatment. Recording a women as having CT when 
the infection was treated will result in mismeasurement of the exposure. In this situation, a cross-
sectional study of the association between CT and adverse pregnancy outcomes could, paradoxically, 
provide a less biased effect estimate than a cohort or case-control study in which women were 
treated (Figure 1). In a cross-sectional study, a positive test result for CT taken at the time of delivery 
means that an untreated infection was present before or during pregnancy (or there is 
persistence/re-infection of a treated infection). The measured association is between untreated CT 
and pregnancy outcome (if adjusted for confounding). In cohort and case-control studies, CT tests 
are either done prospectively or records of tests done during pregnancy are sought. Women with CT 
diagnosed during pregnancy are likely to have been treated so the measured association is between 
treated CT and pregnancy outcomes. Tang et al. found that summary estimates in meta-analyses of 
preterm labour and spontaneous abortion (but not low birth weight and premature rupture of 
membranes) were higher for cross-sectional than either cohort or case-control studies. There were 
no cross-sectional studies details of other pregnancy outcomes and Tang et al. reported that details 
of CT testing and treatment were very rarely reported in the included studies. 
What do we want to know? 
STI practitioners and researchers probably want to know whether CT infection in pregnancy is an 
important cause of poor reproductive health outcomes. Tang et al.’s review shows associations with 
several adverse outcomes. Because of the wide scope of the review, there was little opportunity to 
discuss the questions about causality or of potential mechanisms for individual outcomes. For 
example, the authors suggest that there is increased evidence of associations with stillbirth and 
spontaneous abortion.6 But these associations were only present in unadjusted analyses and the 
certainty of the body of evidence was assessed as low or very low.  
The systematic review by Tang et al. does not allow a precise quantification of the causal association 
between CT infection and the multiple potential adverse outcomes for women’s reproductive 
health. Their findings will, however, be relevant to the interpretation of systematic reviews of 
associations between other sexually transmitted and genital tract infections and pregnancy 
outcomes.8 12 13 The review also highlights methodological issues that researchers can take into 
account for future studies. Individual studies of associations between genital tract infections and 
pregnancy outcomes should examine a full range of potential pathogens, including the vaginal 
microbiota, record the timing of testing and treatment for infection, and both measure and control 
for confounding factors. Improved reporting of observational studies14 will make it easier for results 
to be incorporated in systematic reviews.7 Doing a systematic review requires more than following a 
recipe. In systematic reviews of observational studies authors should consider in advance what are 
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the important confounding factors for each exposure-outcome pair, show results of both unadjusted 
and confounder-adjusted estimates, and assess the risk of bias considering that sources of bias may 
be specific to different research questions and study designs. 
Improved reproductive health outcomes are a major international goal for women and their families, 
for clinical medicine, and for public health. Systematic reviews can help to investigate the potential 
population impact of interventions. The studies identified and included will point to gaps in the 
evidence and summary effect sizes can be used to estimate population attributable fractions 
(bearing in mind the strong assumptions about causality). Ultimately, randomised controlled trials of 
different interventions, with clinical outcomes, in settings with low and high levels of CT and co-
infection prevalence will be needed to determine whether screening and treatment to prevent 
adverse pregnancy outcomes do more good than harm at reasonable cost. 
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Figure 1. Observational epidemiological study designs to examine the association between CT and 
pregnancy outcomes, and the temporal relationship between detection of CT, with Rx if CT+, and 
pregnancy outcome. The thick solid line indicates the course of pregnancy, with delivery at the end. 
In a cohort study, CT infection status is determined during pregnancy and, if present, is usually 
treated. The dashed line, with arrow pointing to the end of pregnancy, shows when the outcome is 
ascertained. In a case-control study, the dashed line starting at the end of pregnancy shows that the 
outcome is ascertained at delivery. The arrow points back in time to show that CT infection status is 
often determined through a lookback in medical records and, if detected, is likely to have been 
treated. In a cross-sectional study, both outcome and CT infection status are determined at the end 
of pregnancy and CTI infection is likely to be untreated.  
Abbreviations: CT, Chlamydia trachomatis; CT+, CT-infected; CT-, CT-uninfected; Rx, treatment. 
 
 
